SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudy Saucillo who wrote (1423)7/12/1998 2:24:00 PM
From: jbershad  Read Replies (1) of 2173
 
To all. MM states that this could be a buy in by
by some company. (Big Pharm.) Company (AMLN) already stated
it would not further dilute stock. This stock issuance is for
10% of amln. (Just about equal to the amount J&J holds now.)
He also states the testing in Europe is more important
than the new tests in the U.S.

Good chance something will come out of it.

For you worried souls the drug is worth something.
Anybody buying in now is getting a bargain.

The final terms of the offering are not clear. We most
wait to see what they are.

Jerry

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext